Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Alessandro Zanasi (Bologna, Italy), Alessandro Zanasi, Luigi Lanata, Federico Saibene, Francesco De Blasio. LATE-BREAKING ABSTRACT: Observational study on effectiveness of the combination of antitussives and NASAIDs in patients with URTI related cough. Eur Respir J 2015; 46: Suppl. 59, 3852

Member's Comments

No comment yet.

Related content which might interest you: Comparable effectiveness of budesonide/formoterol combination and fluticasone for the treatment of cough variant asthma Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 LATE-BREAKING ABSTRACT: Antitussive effect of a diphenhydramine-containing multicomponent cough syrup in acute viral cough. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 LATE-BREAKING ABSTRACT: A dose-ranging study of dupilumab in patients (pts) with uncontrolled asthma despite use of inhaled corticosteroids plus a long-acting beta-agonist (ICS/LABA): Final data Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 LATE-BREAKING ABSTRACT: beta-blockers are associated with a reduction in COPD exacerbations in COPDGene Source: International Congress 2014 – COPD exacerbations Year: 2014 LATE-BREAKING ABSTRACT: Tackling the burden of chronic cough: A dose escalation study of AF-219 Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 Effect of cromolyn inhaler on resistant neutrophilic cough variant of asthma, A phase two clinical trial Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 LATE-BREAKING ABSTRACT: Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: the SIRIUS study Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 LATE-BREAKING ABSTRACT: Once-daily tiotropium Respimat® add-on therapy improves lung function in children with moderate symptomatic asthma Source: International Congress 2016 – Living with asthma around the globe Year: 2016 LATE-BREAKING ABSTRACT: Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 LATE-BREAKING ABSTRACT: Safety and tolerability of once-daily tiotropium Respimat® add-on therapy in children with moderate symptomatic asthma Source: International Congress 2016 – Living with asthma around the globe Year: 2016 Codeine for treatment of cough variant asthma Source: International Congress 2016 – Asthma points to ponder Year: 2016 Maintenance and reliever combination budesonide/formoterol therapy in asthma patients at risk of severe exacerbations: A randomised controlled trial Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013 The effect of treatment duration by inhaled glucocorticosteroids, on “cough variant asthma” in children Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013 QVA149 improves dyspnoea and lung function versus tiotropium in symptomatic patients using LABA/ICS preceding study enrolment: The BLAZE study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 LATE-BREAKING ABSTRACT: Benralizumab reduces exacerbations in severe, uncontrolled asthma: Results of the phase III CALIMA trial Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 LATE-BREAKING ABSTRACT: Cost-effectiveness of the LABA/LAMA dual bronchodilator QVA149 in a Swedish setting Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013 LATE-BREAKING ABSTRACT: Is treatment with inhaled corticosteroids in asthma associated with hospitalisations because of pneumonia? Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016 Efficacy and response predictors of inhaled corticosteroid treatment on chronic cough Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 LATE-BREAKING ABSTRACT: Glycopyrronium once-daily significantly improves lung function and health status when added to fluticasone/salmeterol in patients with COPD: The GLISTEN study Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 LATE-BREAKING ABSTRACT: Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD patients Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015